Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 20;30(4):4289-4300.
doi: 10.3390/curroncol30040327.

Clinicopathological Characteristics, Treatment Patterns, and Outcomes in Patients with Laryngeal Cancer

Affiliations

Clinicopathological Characteristics, Treatment Patterns, and Outcomes in Patients with Laryngeal Cancer

Dejan Đokanović et al. Curr Oncol. .

Abstract

Background: Various factors can affect the survival of patients with laryngeal cancer (LC). In this retrospective study, we assessed clinicopathological features, their prognostic value, and treatment modalities for patients with confirmed squamous cell LC.

Methods: We collected patient data on demographics, clinicopathological characteristics, treatment patterns, and outcomes. The primary endpoints were overall survival (OS), disease-specific survival (DSS), disease-free survival (DFS), and locoregional control (LRC). We assessed survival using the Kaplan-Meier method and Cox regression model analyses of potential prognostic parameters.

Results: After a median follow-up of 76 months, 28 (33.3%) patients had a recurrence. The median OS was 78 months, with an event recorded in 50% of patients. The DSS median was not reached (NR) with a survival rate of 72.6%, the DFS survival rate was 66.7% with median NR, and the LRC survival rate was 72.6% with median NR. After conducting a multivariate analysis of significant variables, we found that only recurrence and lymphatic invasion had an independent effect on OS and recurrence in DSS, while subsite impacted DFS and LRC.

Conclusions: Survival trends were consistent with other studies, except for OS. Recurrence, lymphatic invasion, and subsite location were significant factors that impacted patient survival.

Keywords: laryngeal cancer; prognosis; recurrence; survival.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of patient selection.
Figure 2
Figure 2
(a) Kaplan–Meier curve showing OS, median 78 months; (b) DSS, median NR; (c) DFS, median NR; (d) LRC, median NR.
Figure 3
Figure 3
Kaplan–Meier curve showing OS in different treatment groups, log-rank p = 0.009.

References

    1. Fitzmaurice C., Abate D., Abbasi N., Abbastabar H., Abd-Allah F., Abdel-Rahman O., Abdelalim A., Abdoli A., Abdollahpour I., Abdulle A.S.M., et al. Global Burden of Disease Cancer Collaboration Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2019;5:1749–1768. doi: 10.1001/jamaoncol.2019.2996. Erratum in: JAMA Oncol. 2020, 6, 444. Erratum in: JAMA Oncol. 2020, 6, 789; Erratum in JAMA Oncol. 2021, 7, 466. - DOI - PMC - PubMed
    1. Bradley P.J. Laryngeal cancer in nondrinker nonsmoker young patients: A distinct pathological entity? Curr. Opin. Otolaryngol. Head Neck Surg. 2016;24:140–147. doi: 10.1097/MOO.0000000000000230. - DOI - PubMed
    1. Aupérin A. Epidemiology of head and neck cancers: An update. Curr. Opin. Oncol. 2020;32:178–186. doi: 10.1097/CCO.0000000000000629. - DOI - PubMed
    1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2016. CA Cancer J. Clin. 2016;66:7–30. doi: 10.3322/caac.21332. - DOI - PubMed
    1. Groome P.A., O’Sullivan B., Irish J.C., Rothwell D.M., Schulze K., Warde P.R., Schneider K.M., Mackenzie R.G., Hodson D.I., Hammond J.A., et al. Management and outcome differences in supraglottic cancer between Ontario, Canada, and the Surveillance, Epidemiology, and End Results areas of the United States. J. Clin. Oncol. 2003;21:496–505. doi: 10.1200/JCO.2003.10.106. - DOI - PubMed

Publication types

LinkOut - more resources